Pedram Argani Selected Research

Cyclin D2

9/2008	Quantitative promoter hypermethylation profiles of ductal carcinoma in situ in North American and Korean women: Potential applications for diagnosis.
7/2007	A comparative study of Korean with Caucasian breast cancer reveals frequency of methylation in multiple genes correlates with breast cancer in young, ER, PR-negative breast cancer in Korean women.
5/2004	Very high frequency of hypermethylated genes in breast cancer metastasis to the bone, brain, and lung.
3/2004	Estrogen receptor/progesterone receptor-negative breast cancers of young African-American women have a higher frequency of methylation of multiple genes than those of Caucasian women.
12/2003	DNA methylation of RASSF1A, HIN-1, RAR-beta, Cyclin D2 and Twist in in situ and invasive lobular breast carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pedram Argani Research Topics

Disease

130	Neoplasms (Cancer) 01/2022 - 01/2002
53	Breast Neoplasms (Breast Cancer) 01/2022 - 04/2003
42	Renal Cell Carcinoma (Grawitz Tumor) 01/2022 - 06/2003
40	Carcinoma (Carcinomatosis) 01/2022 - 09/2002
26	Neoplasm Metastasis (Metastasis) 12/2021 - 01/2002
12	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2022 - 04/2003
9	Ductal Carcinoma 01/2022 - 04/2003
8	Perivascular Epithelioid Cell Neoplasms 05/2021 - 04/2009
8	Adenocarcinoma 01/2021 - 01/2002
8	Cholangiocarcinoma 09/2017 - 12/2002
7	Kidney Neoplasms (Kidney Cancer) 05/2021 - 02/2005
7	Wilms Tumor (Wilm's Tumor) 01/2020 - 09/2003
7	Sarcoma (Soft Tissue Sarcoma) 01/2020 - 05/2004
7	Alveolar Soft Part Sarcoma 01/2016 - 06/2003
6	Carcinogenesis 09/2017 - 01/2003
6	Pancreatic Neoplasms (Pancreatic Cancer) 07/2006 - 01/2002
5	Angiomyolipoma 08/2021 - 01/2008
5	Genetic Translocation (Chromosomal Translocation) 11/2020 - 02/2007
4	Cysts 10/2018 - 05/2006
3	Leiomyomatosis 01/2021 - 11/2014
3	Synovial Sarcoma (Synovioma) 01/2020 - 01/2003
3	Melanoma (Melanoma, Malignant) 01/2020 - 02/2013
3	Oxyphilic Adenoma (Oncocytoma) 12/2018 - 08/2013
3	Lobular Carcinoma 11/2017 - 12/2003
3	Papillary Carcinoma 11/2014 - 06/2006
3	Disease Progression 07/2012 - 03/2006
3	Breast Diseases (Breast Disease) 09/2006 - 12/2004
2	Tuberous Sclerosis (Bourneville's Disease) 01/2022 - 01/2012
2	Microphthalmos 01/2022 - 02/2020
2	Mesothelioma 01/2021 - 11/2020
2	Chronic Kidney Failure (Chronic Renal Failure) 10/2018 - 05/2011
2	Neuroblastoma 01/2018 - 12/2007
2	Medullary Carcinoma 01/2018 - 07/2014
2	Necrosis 01/2018 - 12/2006
2	Pathologic Complete Response 03/2016 - 12/2010

Drug/Important Bio-Agent (IBA)

39	Proteins (Proteins, Gene)FDA Link 10/2021 - 12/2002
23	Estrogen ReceptorsIBA 01/2022 - 03/2004
19	Transcription Factors (Transcription Factor)IBA 01/2022 - 01/2003
17	Biomarkers (Surrogate Marker)IBA 05/2021 - 01/2003
16	DNA (Deoxyribonucleic Acid)IBA 05/2014 - 01/2002
14	Progesterone Receptors (Progesterone Receptor)IBA 03/2016 - 03/2004
13	Cathepsin KIBA 05/2021 - 09/2008
10	RNA (Ribonucleic Acid)IBA 01/2022 - 05/2002
10	Messenger RNA (mRNA)IBA 01/2021 - 03/2003
10	Phenobarbital (Luminal)FDA Link 08/2015 - 02/2009
8	EnzymesIBA 12/2021 - 01/2003
8	ParaffinIBA 10/2012 - 11/2002
7	Hormones (Hormone)IBA 01/2020 - 05/2006
6	Keratins (Keratin)IBA 01/2022 - 12/2002
6	Biological ProductsIBA 11/2020 - 07/2004
5	Anaplastic Lymphoma KinaseIBA 01/2022 - 06/2014
5	MART-1 AntigenIBA 04/2020 - 01/2008
5	Estrogens (Estrogen)FDA Link 12/2015 - 06/2006
5	Cyclin D2IBA 09/2008 - 12/2003
5	retinoic acid receptor betaIBA 09/2008 - 10/2003
5	AntigensIBA 03/2004 - 12/2002
4	trans-sodium crocetinate (crocetin)IBA 01/2022 - 01/2018
4	TOR Serine-Threonine KinasesIBA 01/2022 - 09/2012
4	Fumarate Hydratase (Fumarase)IBA 01/2021 - 01/2018
4	ChromatinIBA 01/2021 - 04/2010
4	Phosphotransferases (Kinase)IBA 10/2020 - 08/2004
4	Formaldehyde (Formol)FDA Link 09/2012 - 01/2003
4	Telomerase (Telomerase Reverse Transcriptase)IBA 10/2011 - 05/2004
4	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 08/2010 - 01/2002
3	Cyclin D1IBA 01/2022 - 09/2003
3	S100 Proteins (S 100 Protein)IBA 01/2022 - 06/2006
3	DesminIBA 01/2022 - 08/2013
3	Succinate Dehydrogenase (Fumarate Reductase)IBA 01/2021 - 10/2013
3	Microphthalmia-Associated Transcription FactorIBA 01/2021 - 12/2007
3	Estrogen Receptor alphaIBA 07/2018 - 09/2008
3	Epidermal Growth Factor (EGF)IBA 11/2017 - 03/2016
3	Carrier Proteins (Binding Protein)IBA 01/2015 - 12/2013
3	Androgen Receptors (Androgen Receptor)IBA 09/2014 - 02/2012
3	MucinsIBA 11/2013 - 12/2006
3	hydrogen sulfite (bisulfite)IBA 02/2009 - 01/2002
3	beta CateninIBA 12/2007 - 09/2003
3	MethyltransferasesIBA 05/2007 - 10/2003
3	MesothelinIBA 03/2004 - 09/2003
2	Glycoproteins (Glycoprotein)IBA 01/2022 - 12/2021
2	VinculinIBA 01/2022 - 06/2014
2	Epithelial Cell Adhesion MoleculeIBA 12/2021 - 10/2010
2	ChromograninsIBA 11/2021 - 12/2018
2	SynaptophysinIBA 11/2021 - 12/2018
2	InterferonsIBA 08/2021 - 08/2012
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2020 - 01/2019
2	Keratin-7 (Cytokeratin 7)IBA 12/2018 - 11/2014
2	Coloring Agents (Dyes)IBA 10/2018 - 12/2016
2	MicroRNAs (MicroRNA)IBA 01/2017 - 06/2014
2	human ERBB2 proteinIBA 03/2016 - 07/2015
2	LigandsIBA 03/2016 - 10/2004
2	B7-H1 AntigenIBA 03/2016 - 01/2016
2	Tamoxifen FDA LinkGeneric 12/2014 - 01/2008
2	AndrogensIBA 09/2014 - 02/2012
2	A 7 (A-7)IBA 09/2014 - 02/2009
2	Circulating Tumor DNAIBA 04/2014 - 06/2012

Therapy/Procedure

40	Therapeutics 05/2021 - 05/2004
13	Drug Therapy (Chemotherapy) 01/2021 - 09/2005
12	Nephrectomy 01/2019 - 10/2005
6	Mastectomy (Mammectomy) 01/2020 - 07/2006
2	Neoadjuvant Therapy 03/2016 - 07/2015